Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
The Minneapolis VA Healthcare System, situated in Minneapolis, MN, provides extensive rehabilitation programs designed for adults and young adults. Their expertise lies in detox, addiction recovery, and comprehensive treatment for individuals facing both substance use challenges and serious mental health or emotional concerns in children. The center offers robust outpatient services, including intensive programs, standard outpatient care, and detox. They emphasize approaches like 12-step facilitation, anger management, and brief interventions. The Minneapolis VA Healthcare System is equipped to support clients with trauma histories, co-occurring mental health and substance use disorders, and veterans specifically. Serving all genders, this facility is dedicated to delivering exceptional care and assistance to those on their journey to recovery.
Minnesota Adult and Teen Challenge, located in Minneapolis, MN, provides an extensive array of services for those struggling with addiction. This center specializes in detoxification, addiction therapy, and targeted support for individuals facing both substance use disorders and serious mental health conditions in adults, along with emotional challenges in children. With options for residential detox, around-the-clock supervision, and short-term residential programs, the facility customizes its treatment to meet personal needs. Employing methods such as 12-step programs, anger management, and cognitive behavioral therapy, the center promotes a thorough and well-rounded recovery journey. It also offers specific programs tailored for teenagers, adult men, and adult women. Catering to diverse age groups and genders, Minnesota Adult and Teen Challenge emphasizes high-quality care and personalized treatment planning.
Situated in Northridge, CA, Miracles in Action delivers a wide array of rehabilitation services aimed at those struggling with substance use and concurrent mental health issues. The center features multiple treatment options, including intensive outpatient programs, outpatient day therapy, and partial hospital services, employing techniques such as 12-step facilitation, anger management, and concise interventions. This facility includes specialized programs designed for active duty military personnel, youth, and adult males, and it accommodates individuals of all genders, both adults and children/adolescents. Miracles in Action is committed to offering high-quality care and support to facilitate enduring recovery and enhance overall health.
Mirmont Treatment Center, situated in Media, PA, delivers a variety of specialized services aimed at helping adults and young adults grapple with addiction. The facility features detoxification programs, treatment for substance use, and support for co-occurring mental health disorders. It offers multiple levels of care, including intensive outpatient, outpatient, and day treatment, all rooted in evidence-based practices such as 12-step programs, anger management techniques, and brief intervention strategies. Additionally, Mirmont has designed specific programs for active duty service members, as well as distinct services for adult men and women. This center prioritizes comprehensive care and assistance for individuals striving for recovery from addiction and mental health issues.
MiraVista Behavioral Health Center, situated in Holyoke, MA, specializes in providing treatment programs for substance use tailored to both adults and young adults. The facility offers a variety of outpatient services, including intensive outpatient treatment along with methadone/buprenorphine or naltrexone options. By employing evidence-based methods such as cognitive behavioral therapy, 12-step facilitation, and motivational interviewing, MiraVista ensures that each client receives personalized care. The center also features specialized programs for individuals with HIV or AIDS and pregnant or postpartum women, addressing unique needs with empathy and professionalism. With a focus on delivering exceptional care, both male and female clients are supported in their journey toward recovery from substance use disorders.
MiraVista Behavioral Health Center, situated in Holyoke, MA, provides outpatient detox and treatment options for both adults and young adults dealing with substance use issues. The facility excels in techniques such as motivational interviewing and relapse prevention, along with counseling dedicated to substance use disorders. Specific programs are designed to support clients who are pregnant or postpartum, as well as those living with HIV or AIDS. Emphasizing high-quality care, MiraVista accommodates both male and female clients, ensuring a tailored and supportive approach to addiction recovery and detoxification.
Mind Dojo in Irwin, Pennsylvania, delivers outpatient and intensive outpatient addiction treatment with buprenorphine and naltrexone for adolescents, adults, and seniors, including veterans, pregnant women, and trauma survivors. Spanish-language services are available. TRICARE, private health insurance, and self-payment are accepted.
Outpatient substance use and co-occurring disorders care in Ann Arbor, Michigan, with buprenorphine and naltrexone available. Mindful Care serves all age groups from adolescents to seniors, including veterans, criminal justice clients, and pregnant women. Medicare, Medicaid, TRICARE, and private insurance are accepted.
This Prescott Valley, Arizona youth treatment center provides hospital inpatient and residential substance use care exclusively for children and adolescents, including those with co-occurring disorders and trauma histories. Naltrexone is used. Medicaid, TRICARE, tribal funds, and SAMHSA block grants are accepted.
Mingus Mountain Academy's Farrington House in Dewey, Arizona is a residential and hospital inpatient program for children and adolescents, using naltrexone and serving trauma survivors and criminal justice clients. Medicaid, TRICARE, tribal funds, SAMHSA block grants, and Spanish-language services are available.
This Rice Lake, WI, VA clinic provides outpatient substance use treatment for veterans, including buprenorphine and naltrexone for opioid use disorder. Programs also address co-occurring mental health conditions and trauma in adults of all ages. Medicare, Medicaid, TRICARE, private insurance, and self-payment are accepted.
Veterans in the Hayward, WI, area can receive outpatient substance use treatment at this VA community clinic, including buprenorphine and naltrexone for opioid use disorder. Programs address co-occurring mental health conditions and trauma. Medicare, Medicaid, TRICARE, private insurance, and federal funding are accepted.
Hospital inpatient substance use treatment with buprenorphine and naltrexone is offered at Mirasol Center for Healing in Jamaica Plain, Massachusetts. Specialized programs cover active duty military, veterans, pregnant and postpartum women, and clients with co-occurring mental and pain disorders. Medicaid, Medicare, TRICARE, and SAMHSA block grant funding are accepted. Spanish and Portuguese services available.
Mirmont Outpatient Center in Exton, PA, provides focused treatment for adults facing co-occurring mental health and substance use disorders, as well as for children experiencing emotional challenges. Their robust outpatient day treatment and intensive outpatient services employ scientifically validated methods like cognitive behavioral therapy and motivational interviewing. Catering specifically to adolescents and individuals involved with the criminal justice system, the center delivers customized care for all genders. This facility stands out for its dedication to high-quality, personalized rehabilitation, making it a premier option for individuals in Exton seeking comprehensive support.
Outpatient substance use treatment in San Antonio, Texas, with buprenorphine and naltrexone available on an outpatient basis. Mindful Innovations Csl Servs PLLC serves adolescents, pregnant and postpartum women, veterans, active duty military, and clients with co-occurring disorders. Spanish-language services are offered, and Medicare, Medicaid, and TRICARE are accepted.
The Chippewa Valley CBOC of the Minneapolis VA Medical Center in Chippewa Falls, Wisconsin, provides outpatient substance use treatment for veterans, including those with co-occurring mental health disorders or trauma histories. Buprenorphine and naltrexone are used in treatment. Medicare, Medicaid, TRICARE, and private insurance are among the accepted payment forms.
"Mind Body Solutions, located in Las Vegas, NV, offers a comprehensive range of outpatient services for detoxification, substance use treatment, and co-occurring conditions in adults and children/adolescents. The facility provides specialized programs for active duty military, adolescents, and adult men, catering to a diverse population. With treatment formats including outpatient detoxification and methadone/buprenorphine/naltrexone therapy, the center utilizes evidence-based approaches such as anger management, brief intervention, and contingency management to promote recovery. Serving both male and female clients, this facility focuses on delivering high-quality care to support individuals on their path to wellness."
In Minden, LA, Minden Behavioral Health Clinic delivers expert care for addiction and accompanying mental health conditions in individuals of all ages. Their services encompass various treatment modalities such as intensive outpatient, standard outpatient, and medication-assisted treatment using methadone, buprenorphine, or naltrexone. Utilizing therapeutic strategies including anger management, brief intervention, and cognitive behavioral therapy, the clinic personalizes treatment plans. Minden Behavioral Health Clinic offers specialized tracks for adult men, adult women, and those with dual diagnoses, serving adults and older adults of any gender who are looking for thorough and empathetic support.
Regular and intensive outpatient substance use treatment in Halethorpe, MD, with buprenorphine and naltrexone for opioid use disorder. Mine Healthcare Services LLC treats young adults, adults, and seniors, including those with co-occurring serious mental illness, and accepts Medicare and Medicaid.
Situated in Broomall, PA, Mirmont Outpatient Center presents a variety of specialized treatment options for individuals dealing with substance use issues and co-existing mental health challenges. This establishment features intensive outpatient, outpatient, and day treatment services, emphasizing evidence-backed practices such as 12-step programs, anger management sessions, and brief therapeutic interventions. With dedicated programs for young adults and adolescents, the center accommodates clients of all genders and ages. Mirmont's emphasis on quality care and personalized treatment strategies positions it as an essential resource for those in search of thorough rehabilitation support in Broomall.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.